RAB42 and liver cancer: The results showed the proportion of EdU-positive cells was significantly decreased with the transfection of siRAB42 in SMMC7721 and Hep3B cells, indicating that knockdown of RAB42 significantly inhibited the proliferation of liver cancer cells (Figures 10C–F).